Search NLS News

The Board of Directors of Moberg Pharma has resolved to carry out a fully guaranteed issue of new ordinary shares with preferential rights for existing shareholders of approximately SEK 121 million before transaction costs. The Rights Issue is conditional upon approval at an extraordinary general meeting, states the company. “The financing we have secured gives […]

Professor Trine Hyrup Mogensen from Aarhus University will study why some people suffer from serious COVID-19 infections, while others do not become ill at all, even when exposed to massive infection. Hyrup Mogensen, who is a professor at the Department of Biomedicine and a medical doctor at the Department of Infectious Diseases at Aarhus University […]

Researchers at Karolinska Institutet have developed a new strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging SARS-CoV-2 variants. The approach led to the discovery of multiple nanobodies that in cell cultures and mice effectively blocked infection with different SARS-CoV-2 variants. “With the help of advanced laboratory techniques, we were able to identify a […]

Elypta has announced the launch of its second clinical study intended to validate the diagnostic performance of GAGomes – the complete profile of human glycosaminoglycans – as metabolic biomarkers for Multi-Cancer Early Detection (MCED). This study, LEVANTIS-0093A (LEV93A), aims to detect any-type cancer in adults at high risk of developing cancer due to significant smoking […]

Anocca has announced the appointment of Dr. Michael Kalos to its Scientific Advisory Board. As Anocca plans for clinical development and accelerates discovery efforts, Dr. Kalos strengthens Anocca’s internationally recognised SAB, joining Professors Adnane Archour, Rolf Kiessling and Klas Kärre, from Karolinska Institutet, Stockholm, and Professor Michael Nishimura, from Loyola University Chicago. “We’re delighted to […]

Sweden’s Minister of Health and Social Affairs, Lena Hallengren, has officially inaugurated Valneva Sweden’s new COVID-19 vaccine manufacturing facility, the first and only one of its kind in Sweden. “The fact that COVID-19 vaccines are manufactured in Sweden is a progress that indicate the strength of the Swedish model where companies and the society cooperate […]

Elicera Therapeutics have announced the publication of a scientific article describing the mechanism-of-action of the company’s universal CAR T-cell enhancement technology platform iTANK in Nature Biomedical Engineering. Proof-of-concept data presented in the publication also indicate that the iTANK-platform is universally compatible with other CAR T-cell therapies, states the company in a press release. The iTANK-platform […]

Sobi has announced that its contract with Pfizer for the manufacture of drug substance for ReFacto AF/Xyntha (ReFacto) has been amended due to clarity of final order volumes and will now expire in the first quarter of 2024, earlier than the previous expiry date at the end of 2025. Manufacturing of drug substance for ReFacto […]

The two companies have signed a global commercial collaboration agreement in the field of radiation oncology. The collaboration enables them to provide hospitals a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy, they state. “Combining GE Healthcare’s imaging solutions with Elekta’s radiation therapy solutions will result in an even more compelling […]

Idogen has signed a strategic collaboration agreement with two contract research organizations, Danish Klifo and Finnish 4Pharma, which will together with Idogen run the clinical phase 1/2a study with IDO 8. IDO 8 is a new cell therapy for patients with severe hemophilia who have developed antibodies to their treatment with coagulation factor VIII. The […]